miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway
出版年份 2017 全文链接
标题
miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway
作者
关键词
-
出版物
Oncogenesis
Volume 6, Issue 5, Pages e326
出版商
Springer Nature
发表日期
2017-05-01
DOI
10.1038/oncsis.2017.25
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma
- (2016) Li Wang et al. Diagnostic Pathology
- Erratum to: Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy
- (2016) Evelyn Despierre et al. Targeted Oncology
- miR-34C Disrupts the Stemness of Purified CD133 + Prostatic Cancer Stem Cells
- (2016) Yuan Chen et al. UROLOGY
- Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells
- (2016) Cynthia Morata-Tarifa et al. Scientific Reports
- Amphiregulin confers trastuzumab resistance via AKT and ERK activation in HER2-positive breast cancer
- (2015) Ji-Won Kim et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- MicroRNA-34c-5p is related to recurrence in laryngeal squamous cell carcinoma
- (2015) Massimo Re et al. LARYNGOSCOPE
- An antibody to amphiregulin, an abundant growth factor in patients’ fluids, inhibits ovarian tumors
- (2015) S Carvalho et al. ONCOGENE
- The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels
- (2015) Helena K. Fritz et al. PLoS One
- MiR-34a suppresses amphiregulin and tumor metastatic potential of head and neck squamous cell carcinoma (HNSCC)
- (2015) Jiali Zhang et al. Oncotarget
- miR-34 and p53: New Insights into a Complex Functional Relationship
- (2015) Francisco Navarro et al. PLoS One
- Functional Analysis of miR-34c as a Putative Tumor Suppressor in High-Grade Serous Ovarian Cancer1
- (2014) Zhifeng Yu et al. BIOLOGY OF REPRODUCTION
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Developing ovarian cancer stem cell models: laying the pipeline from discovery to clinical intervention
- (2014) Brendan Ffrench et al. Molecular Cancer
- DDB2 Suppresses Tumorigenicity by Limiting the Cancer Stem Cell Population in Ovarian Cancer
- (2014) Chunhua Han et al. MOLECULAR CANCER RESEARCH
- Quantitative Proteomic Analysis of Gene Regulation by miR-34a and miR-34c
- (2014) Olivia A. Ebner et al. PLoS One
- The microRNA miR-34a Inhibits Non-Small Cell Lung Cancer (NSCLC) Growth and the CD44hi Stem-Like NSCLC Cells
- (2014) Yang Shi et al. PLoS One
- Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy
- (2014) Suping Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amphiregulin
- (2014) Carmen Berasain et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma
- (2014) Qin Xu et al. TUMOR BIOLOGY
- The role of microRNAs in hepatocyte nuclear factor-4alpha expression and transactivation
- (2013) Zhongyan Wang et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A microRNA miR-34a-Regulated Bimodal Switch Targets Notch in Colon Cancer Stem Cells
- (2013) Pengcheng Bu et al. Cell Stem Cell
- MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1
- (2013) Wenxing Qin et al. FEBS LETTERS
- Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma
- (2013) Xiaoxiang Chen et al. HUMAN PATHOLOGY
- MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α
- (2013) Yu-Ming Yeh et al. INTERNATIONAL JOURNAL OF CANCER
- Promoter methylation of AREG, HOXA11, hMLH1, NDRG2, NPTX2 and Tes genes in glioblastoma
- (2013) Daina Skiriutė et al. JOURNAL OF NEURO-ONCOLOGY
- Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden
- (2013) Khalid Abubaker et al. Molecular Cancer
- Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer
- (2013) N Panupinthu et al. ONCOGENE
- Induction of amphiregulin by p53 promotes apoptosis via control of microRNA biogenesis in response to DNA damage
- (2013) N. Taira et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition
- (2013) Dengyu Chen et al. Journal of Ovarian Research
- Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites
- (2012) My Wintzell et al. BMC CANCER
- The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells
- (2012) Dongming Liang et al. BMC CANCER
- Repeated cisplatin treatment can lead to a multiresistant tumor cell population with stem cell features and sensitivity to 3-bromopyruvate
- (2012) My Wintzell et al. CANCER BIOLOGY & THERAPY
- Ovarian cancer stem cell markers: Prognostic and therapeutic implications
- (2012) Daniela Burgos-Ojeda et al. CANCER LETTERS
- Ovarian cancer stem cells: Working towards the root of stemness
- (2012) Rosemary Foster et al. CANCER LETTERS
- Vav3-Rac1 Signaling Regulates Prostate Cancer Metastasis with Elevated Vav3 Expression Correlating with Prostate Cancer Progression and Posttreatment Recurrence
- (2012) K.-T. Lin et al. CANCER RESEARCH
- CD44+/CD24− ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival
- (2012) Erhong Meng et al. CLINICAL & EXPERIMENTAL METASTASIS
- Role of Farletuzumab in Epithelial Ovarian Carcinoma
- (2012) Danijela Jelovac et al. CURRENT PHARMACEUTICAL DESIGN
- MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells
- (2012) Weiwei Cheng et al. FEBS Journal
- MicroRNA MiR-214 Regulates Ovarian Cancer Cell Stemness by Targeting p53/Nanog
- (2012) Cheng-Xiong Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cancerous ovarian stem cells: Obscure targets for therapy but relevant to chemoresistance
- (2012) Nuzhat Ahmed et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
- (2012) Jonathan Ledermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of a Potential Ovarian Cancer Stem Cell Gene Expression Profile from Advanced Stage Papillary Serous Ovarian Cancer
- (2012) Vinod Vathipadiekal et al. PLoS One
- Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy
- (2012) S. M. McAuliffe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miR-34 – a microRNA replacement therapy is headed to the clinic
- (2012) Andreas G. Bader Frontiers in Genetics
- Application of Weibull model for survival of patients with gastric cancer
- (2011) Hui P Zhu et al. BMC GASTROENTEROLOGY
- MicroRNA Regulation of Cancer Stem Cells
- (2011) C. Liu et al. CANCER RESEARCH
- Tumor Suppressive MicroRNAs miR-34a/c Control Cancer Cell Expression of ULBP2, a Stress-Induced Ligand of the Natural Killer Cell Receptor NKG2D
- (2011) A. Heinemann et al. CANCER RESEARCH
- MicroRNA 34c Gene Down-regulation via DNA Methylation Promotes Self-renewal and Epithelial-Mesenchymal Transition in Breast Tumor-initiating Cells
- (2011) Fengyan Yu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Feedback regulation of EGFR signalling: decision making by early and delayed loops
- (2011) Roi Avraham et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells
- (2011) J. M. Stewart et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ovarian Epithelial Cancer Stem Cells
- (2011) Irena Conic et al. TheScientificWorldJOURNAL
- Hypoxia inducible factors in cancer stem cells
- (2010) J M Heddleston et al. BRITISH JOURNAL OF CANCER
- Involvement of NF-κB/miR-448 regulatory feedback loop in chemotherapy-induced epithelial–mesenchymal transition of breast cancer cells
- (2010) Q-Q Li et al. CELL DEATH AND DIFFERENTIATION
- Cancer Stem Cells and Self-renewal
- (2010) C. A. O'Brien et al. CLINICAL CANCER RESEARCH
- miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions
- (2010) Zandra Hagman et al. INTERNATIONAL JOURNAL OF CANCER
- Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met
- (2010) Cai INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
- (2010) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- A protocol for immunofluorescence staining of floating neurospheres
- (2010) Ryo Sasaki et al. NEUROSCIENCE LETTERS
- CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
- (2010) M-Q Gao et al. ONCOGENE
- MicroRNAs and Cancer: Short RNAs Go a Long Way
- (2009) Andrea Ventura et al. CELL
- Amphiregulin mediates self-renewal in an immortal mammary epithelial cell line with stem cell characteristics
- (2009) Brian W. Booth et al. EXPERIMENTAL CELL RESEARCH
- Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease
- (2009) Hervé Acloque et al. JOURNAL OF CLINICAL INVESTIGATION
- EMT: When epithelial cells decide to become mesenchymal-like cells
- (2009) Raghu Kalluri JOURNAL OF CLINICAL INVESTIGATION
- MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
- (2009) Qing Ji et al. PLoS One
- Validation of HB-EGF and amphiregulin as targets for human cancer therapy
- (2007) Fusanori Yotsumoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation